Literature DB >> 3421805

How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.

A Georgotas1, R E McCue, T B Cooper, N Nagachandran, I Chang.   

Abstract

Sixty elderly depressed patients who had responded to either nortriptyline hydrochloride or phenelzine sulfate were followed up under double-blind conditions during four to eight months of continuation treatment. Over 70% of patients (43) remained well during this period, while 11 (18.3%) had relapses, three (5.0%) dropped out because of side effects, and three (5.0%) prematurely terminated in good clinical condition. There was no significant difference in the relapse rate between patients receiving nortriptyline (five [16.7%]) and those receiving phenelzine (six [20.0%]). Patients receiving phenelzine were more likely to require dose reductions, and all three patients who dropped out because of side effects were receiving phenelzine. Patients with chronic depression (greater than two years' duration) accounted for all of the relapses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421805     DOI: 10.1001/archpsyc.1988.01800340057008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

Review 1.  Continuation and maintenance therapy with antidepressive agents. An overview of research.

Authors:  A J Loonen; G J Zwanikken
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

Review 2.  Pharmacologic treatment of depression in late life.

Authors:  A J Flint
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

Review 3.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Antidepressant versus placebo for depressed elderly.

Authors:  K Wilson; P Mottram; A Sivanranthan; A Nightingale
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Adjunctive therapy in patients with Alzheimer's disease. A practical approach.

Authors:  J Corey-Bloom; D Galasko
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 6.  Treatment of major depression in later life: a life cycle perspective.

Authors:  C F Reynolds
Journal:  Psychiatr Q       Date:  1997

Review 7.  Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.

Authors:  Jeffrey H Meyer
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

Review 8.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 9.  Prevalence and outcome of partial remission in depression.

Authors:  Richard Tranter; Claire O'Donovan; Praful Chandarana; Sidney Kennedy
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 10.  Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.

Authors:  A J Flint
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.